ACRS Financials
Aclaris Therapeutics Inc - Financial statements & key metrics
Stock Price
$4.43
Market Cap
$283.86M
EPS
$-1.58
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$18.72M
Gross Profit
-
Operating Income
-
Net Income
$-132.06M
EPS (Diluted)
$-1.71
Balance Sheet Highlights
Total Assets
$220.33M
Total Liabilities
$64.77M
Shareholders Equity
-
Cash & Equivalents
$24.57M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-20.07M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-275.7%
Operating Margin
-5.2%
ROE
-1.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ACRS revenue?
ACRS's most recent quarterly revenue was $18.72M. Annual revenue can be calculated by summing the four most recent quarters.
Is ACRS profitable?
ACRS reported a loss of $132.06M in the most recent quarter.
What is ACRS market cap?
ACRS has a market capitalization of $283.86M, making it a small-cap stock.
Does ACRS have debt?
View ACRS's balance sheet for debt information.
What is ACRS cash flow?
Cash flow data is available in the full financial statements.